Severe Asthma: Tezepelumab Medication Study

We are studying if tezepelumab can help patients aged 12 to 80 with severe asthma reduce their daily medication while keeping their symptoms under control.

1-2 years 16-20 visits Confirmation phase (III)No Placebo Cost Reimbursement Standard Medicines InjectionInternal MedicinePulmonology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Tezspire

Tezspire is a medicine used to treat severe asthma by reducing attacks and helping improve breathing.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Tezepelumab

Tezepelumab is a substance that blocks an immune protein to reduce severe asthma attacks and improve breathing for people with uncontrolled asthma.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Pneumocare

Pulmonology

Jambes, Belgium

Universitair Ziekenhuis Gent

Department of Respiratory Medicine

Ledeberg, Belgium

Centre Hospitalier Regional De La Citadelle

Pneumology

Liège, Belgium

Sponsor: AstraZeneca AB

Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.